{"entity":{"id":"nct04309084","kind":"trial","name":"Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma","aka":[],"tldr":"A phase 1 trial of CYNK-001 run by Celularity Incorporated, of unknown status on the registry.","summary":"Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma is a phase 1 interventional study registered as NCT04309084 by Celularity Incorporated, with 29 participants planned, started 2020-05-12. Conditions recorded: Multiple Myeloma, Neoplasm, Plasma Cell, Neoplasms by Histologic Type, Neoplasms, Hemostatic Disorder, Vascular Diseases, Cardiovascular Diseases, Paraproteinemias, Blood Protein Disorders, Hematologic Diseases, Hemorrhagic Disorders, Lymphoproliferative Disorders, Immunoproliferative Disorders, Immune System Diseases, Antineoplastic Agents, Analgesics, Non-Narcotic, Analgesics, Sensory System Agents, Peripheral Nervous System Agents and Physiological Effects of Drugs. Interventions recorded: CYNK-001.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT04309084","url":"https://clinicaltrials.gov/study/NCT04309084"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["multiple-myeloma","metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["cynk-001"],"companies":["celularity"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04309084","phase":"1","setting":"A Phase I Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK 001) in Multiple Myeloma Patients Following Autologous Stem Cell Transplant in the Front-line Setting.","sponsor":"Celularity Incorporated","enrolled":29,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04309084/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"drug":[{"id":"cynk-001","kind":"drug","name":"CYNK-001","route":"/drugs/cynk-001/"}],"company":[{"id":"celularity","kind":"company","name":"Celularity","route":"/companies/celularity/"}]}}